❮ Back to Researchers

Wanrudee Isaranuwatchai

PhD

Affiliate Scientist

Email: Wanrudee.Isaranuwatchai@unityhealth.to

Research Programs

Biography

Dr. Wanrudee Isaranuwatchai is a Scientist at the Li Ka Shing Knowledge Institute of St. Michael’s Hospital.

She is an Interim Director and a Health Economist at the Centre for Excellence in Economic Analysis Research (CLEAR), a part of the HUB Health Research Solutions at St. Michael’s Hospital. She is also an Assistant Professor at the Institute of Health Policy, Management and Evaluation, University of Toronto.

Dr. Isaranuwatchai has collaborated with researchers and decision-makers in various topics areas to help communicate the value of health programs/initiatives using economic evidence. She has experience conducting economic evaluations using person-level data and decision modeling. Dr. Isaranuwatchai’s research focuses on applied economic evaluation (e.g., how to make economic evaluation more useful to researchers, health providers, and decision-makers) and health economics methods.

Recent Publications

  1. Benzies, KM, Aziz, K, Shah, V, Faris, P, Isaranuwatchai, W, Scotland, J et al.. Effectiveness of Alberta Family Integrated Care on infant length of stay in level II neonatal intensive care units: a cluster randomized controlled trial. BMC Pediatr. 2020;20 (1):535. doi: 10.1186/s12887-020-02438-6. PubMed PMID:33246430 PubMed Central PMC7697372.
  2. Clausen, M, Mighton, C, Kiflen, R, Sebastian, A, Dai, WF, Mercer, RE et al.. Use of real-world evidence in cancer drug funding decisions in Canada: a qualitative study of stakeholders' perspectives. CMAJ Open. ;8 (4):E772-E778. doi: 10.9778/cmajo.20200118. PubMed PMID:33234584 PubMed Central PMC7721249.
  3. Wiljer, D, Shi, J, Lo, B, Sanches, M, Hollenberg, E, Johnson, A et al.. Effects of a Mobile and Web App (Thought Spot) on Mental Health Help-Seeking Among College and University Students: Randomized Controlled Trial. J Med Internet Res. 2020;22 (10):e20790. doi: 10.2196/20790. PubMed PMID:33124984 PubMed Central PMC7665949.
  4. Dai, WF, Beca, J, Croxford, R, Isaranuwatchai, W, Menjak, IB, Petrella, TM et al.. Real-world, population-based cohort study of toxicity and resource utilization of second-line ipilimumab for metastatic melanoma in Ontario, Canada. Int J Cancer. 2020; :. doi: 10.1002/ijc.33357. PubMed PMID:33105030 .
  5. Lou, J, Kc, S, Toh, KY, Dabak, S, Adler, A, Ahn, J et al.. Real-world data for health technology assessment for reimbursement decisions in Asia: current landscape and a way forward. Int J Technol Assess Health Care. 2020;36 (5):474-480. doi: 10.1017/S0266462320000628. PubMed PMID:32928330 .
  6. Chen, C, Dieterich, AV, Koh, JJE, Akksilp, K, Tong, EH, Budtarad, N et al.. The physical activity at work (PAW) study protocol: a cluster randomised trial of a multicomponent short-break intervention to reduce sitting time and increase physical activity among office workers in Thailand. BMC Public Health. 2020;20 (1):1332. doi: 10.1186/s12889-020-09427-5. PubMed PMID:32873258 PubMed Central PMC7466487.
  7. Habbous, S, Guo, H, Beca, J, Dai, WF, Isaranuwatchai, W, Cheung, M et al.. The effectiveness of rituximab and HIV on the survival of Ontario patients with diffuse large B-cell lymphoma. Cancer Med. 2020;9 (19):7072-7082. doi: 10.1002/cam4.3362. PubMed PMID:32794362 PubMed Central PMC7541135.
  8. Isaranuwatchai, W, Fazli, GS, Bierman, AS, Lipscombe, LL, Mitsakakis, N, Shah, BR et al.. Universal Drug Coverage and Socioeconomic Disparities in Health Care Costs Among Persons With Diabetes. Diabetes Care. 2020;43 (9):2098-2105. doi: 10.2337/dc19-1536. PubMed PMID:32641377 .
  9. Pempa,, Luz, ACG, Luangasanatip, N, Kingkaew, P, Adhikari, D, Isaranuwatchai, W et al.. Economic evaluation of rotavirus vaccination in children of Bhutan. Vaccine. 2020;38 (32):5049-5059. doi: 10.1016/j.vaccine.2020.05.035. PubMed PMID:32522415 PubMed Central PMC7327517.
  10. Archer, RA, Kapoor, R, Isaranuwatchai, W, Teerawattananon, Y, Giersing, B, Botwright, S et al.. 'It takes two to tango': Bridging the gap between country need and vaccine product innovation. PLoS One. 2020;15 (6):e0233950. doi: 10.1371/journal.pone.0233950. PubMed PMID:32520934 PubMed Central PMC7286512.
Search PubMed

Affiliations & Other Activities

  • Scientist, Li Ka Shing Institute
  • Assistant Professor, Institute for Health Policy, Management and Evaluation, University of Toronto
X